Mina John

6.3k total citations · 1 hit paper
49 papers, 3.3k citations indexed

About

Mina John is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Mina John has authored 49 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Virology, 23 papers in Immunology and 17 papers in Infectious Diseases. Recurrent topics in Mina John's work include HIV Research and Treatment (37 papers), T-cell and B-cell Immunology (15 papers) and Immune Cell Function and Interaction (14 papers). Mina John is often cited by papers focused on HIV Research and Treatment (37 papers), T-cell and B-cell Immunology (15 papers) and Immune Cell Function and Interaction (14 papers). Mina John collaborates with scholars based in Australia, United States and United Kingdom. Mina John's co-authors include S. Mallal, Ian James, Corey Moore, E. McKinnon, David Nolan, Frank Christiansen, Campbell S. Witt, Martyn A. French, Silvana Gaudieri and Patricia Price and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Mina John

49 papers receiving 3.2k citations

Hit Papers

Evidence of HIV-1 Adaptat... 2002 2026 2010 2018 2002 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mina John 1.9k 1.4k 1.1k 979 756 49 3.3k
Ethan Bornstein 2.1k 1.1× 1.1k 0.7× 1.7k 1.5× 695 0.7× 879 1.2× 9 3.4k
Hiroyu Hatano 2.5k 1.3× 1.9k 1.3× 1.2k 1.1× 750 0.8× 754 1.0× 39 3.5k
JoAnn M. Mican 2.6k 1.4× 1.9k 1.3× 1.6k 1.4× 466 0.5× 807 1.1× 48 4.1k
Catherine Rehm 2.2k 1.2× 1.6k 1.1× 924 0.9× 496 0.5× 524 0.7× 42 2.8k
E. McKinnon 1.1k 0.6× 1.3k 0.9× 505 0.5× 1.2k 1.3× 717 0.9× 90 2.9k
Jan Gerstoft 1.6k 0.9× 1.3k 0.9× 1000 0.9× 537 0.5× 895 1.2× 97 3.0k
Laurence Weiss 2.5k 1.3× 1.9k 1.3× 2.7k 2.5× 643 0.7× 1.3k 1.7× 140 5.6k
Robert Asaad 1.3k 0.7× 800 0.6× 1.1k 1.0× 520 0.5× 739 1.0× 40 2.3k
Giuseppe Tambussi 2.7k 1.4× 1.9k 1.3× 2.7k 2.5× 688 0.7× 1.0k 1.4× 149 5.3k
Faroudy Boufassa 2.8k 1.5× 1.9k 1.3× 1.6k 1.5× 573 0.6× 866 1.1× 90 3.7k

Countries citing papers authored by Mina John

Since Specialization
Citations

This map shows the geographic impact of Mina John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina John more than expected).

Fields of papers citing papers by Mina John

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina John. The network helps show where Mina John may publish in the future.

Co-authorship network of co-authors of Mina John

This figure shows the co-authorship network connecting the top 25 collaborators of Mina John. A scholar is included among the top collaborators of Mina John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina John. Mina John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Firth, Martin J., Rebecca Pavlos, Abha Chopra, et al.. (2024). Epistatic interaction between ERAP2 and HLA modulates HIV-1 adaptation and disease outcome in an Australian population. PLoS Pathogens. 20(7). e1012359–e1012359. 1 indexed citations
2.
Leary, Shay, Silvana Gaudieri, Matthew Parker, et al.. (2021). Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level. SHILAP Revista de lepidopterología. 6(2). 27–49. 43 indexed citations
3.
Chopra, Abha, Mina John, Shay Leary, et al.. (2019). Deep sequence analysis of HIV adaptation following vertical transmission reveals the impact of immune pressure on the evolution of HIV. PLoS Pathogens. 15(12). e1008177–e1008177. 18 indexed citations
4.
Ávila‐Ríos, Santiago, Jonathan M. Carlson, Mina John, S. Mallal, & Zabrina L. Brumme. (2019). Clinical and evolutionary consequences of HIV adaptation to HLA. Current Opinion in HIV and AIDS. 14(3). 194–204. 10 indexed citations
5.
Pfafferott, Katja, E. McKinnon, Shahzma Merani, et al.. (2015). Anti-Hepatitis C Virus T-Cell Immunity in the Context of Multiple Exposures to the Virus. PLoS ONE. 10(6). e0130420–e0130420. 2 indexed citations
6.
Pfafferott, Katja, Silvana Gaudieri, Axel Ulsenheimer, et al.. (2011). Constrained Pattern of Viral Evolution in Acute and Early HCV Infection Limits Viral Plasticity. PLoS ONE. 6(2). e16797–e16797. 29 indexed citations
7.
Merani, Shahzma, Danijela Petrović, Ian James, et al.. (2010). Effect of immune pressure on hepatitis C virus evolution: Insights from a single-source outbreak. Hepatology. 53(2). 396–405. 50 indexed citations
8.
Almeida, C., Steven G. Roberts, R. Laird, et al.. (2009). Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses. Journal of Immunological Methods. 344(1). 1–5. 21 indexed citations
9.
Ávila‐Ríos, Santiago, Christopher E. Ormsby, Jonathan M. Carlson, et al.. (2009). Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study. Retrovirology. 6(1). 72–72. 24 indexed citations
10.
Rauch, Andri, David Nolan, Hansjakob Furrer, et al.. (2008). HLA‐Bw4Homozygosity Is Associated with an Impaired CD4 T Cell Recovery after Initiation of Antiretroviral Therapy. Clinical Infectious Diseases. 46(12). 1921–1925. 28 indexed citations
11.
Herrmann, S., et al.. (2007). Evidence‐based, multifactorial approach to addressing non‐adherence to antiretroviral therapy and improving standards of care. Internal Medicine Journal. 38(1). 8–15. 26 indexed citations
12.
McKinnon, E., Ian James, Mina John, & S. Mallal. (2003). Viral load detectability profiles for HIV infection. Statistics in Medicine. 22(3). 385–396. 5 indexed citations
13.
John, Mina, E. McKinnon, Ian James, et al.. (2003). Randomized, Controlled, 48-Week Study of Switching Stavudine and/or Protease Inhibitors to Combivir/Abacavir to Prevent or Reverse Lipoatrophy in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(1). 29–33. 89 indexed citations
14.
Nolan, David, Gerald F. Watts, S. Herrmann, et al.. (2003). Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?. QJM. 96(11). 825–832. 55 indexed citations
15.
16.
Nolan, David, E. McKinnon, Mina John, et al.. (2001). Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS. 15(10). 1275–1280. 135 indexed citations
17.
John, Mina, Corey Moore, Ian James, et al.. (2001). Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS. 15(6). 717–723. 194 indexed citations
18.
Keane, Niamh M., et al.. (2000). Assessment of Immune Function by Lymphoproliferation Underestimates Lymphocyte Functional Capacity in HIV Patients Treated with Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses. 16(18). 1991–1996. 33 indexed citations
19.
Mallal, S., Mina John, Corey Moore, Ian James, & E. McKinnon. (2000). Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS. 14(10). 1309–1316. 415 indexed citations
20.
French, Martyn A., Nat Lenzo, Mina John, et al.. (2000). Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy. HIV Medicine. 1(2). 107–115. 310 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026